Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2023
Filter by date:
Showing 1262 press releases before 2023
-
Imfinzi approved in Japan for the treatment of extensive-stage small cell lung cancer
-
Imfinzi granted FDA Priority Review for less-frequent, fixed-dose use
-
AstraZeneca concludes agreement with the European Commission for the supply of up to 400 million doses of AZD1222 COVID-19 vaccine
-
Nirsevimab reduced respiratory syncytial virus infections and hospitalisations in preterm infants in Phase IIb trial
-
Tagrisso granted Breakthrough Therapy Designation in the US for the adjuvant treatment of patients with Stage IB-IIIA EGFR-mutated lung cancer
-
H1 2020 results
-
Farxiga met all primary and secondary endpoints in groundbreaking Phase III DAPA-CKD trial for the treatment of patients with chronic kidney disease
-
Calquence recommended for approval in the EU by CHMP for chronic lymphocytic leukaemia
-
Imfinzi recommended for approval in the EU by CHMP for extensive-stage small cell lung cancer
-
AstraZeneca and Daiichi Sankyo enter collaboration to develop and commercialise new antibody drug conjugate
Latest articles and press releases
All of our latest press releases and articles are available to explore
Use a maximum of two downloads here